Reuters logo
Sweden's Sobi says terminates takeover talks
June 8, 2015 / 6:27 AM / 2 years ago

Sweden's Sobi says terminates takeover talks

STOCKHOLM, June 8 (Reuters) - Swedish rare diseases drugmaker Swedish Orphan Biovitrum (Sobi) said on Monday it had terminated discussions regarding a non-binding proposal in relation to a possible offer for the company.

The firm said in late April it had received a preliminary proposal for a bid on the company, and Reuters identified Pfizer as the bidder.

“The Board of Directors of Sobi has terminated discussions regarding this proposal,” Sobi said in a statement.

“Sobi will continue to focus on preparations for the upcoming planned launch of Elocta and Alprolix and on building value through its diverse and growing portfolio.”

Reporting by Johannes Hellstrom; editing by Niklas Pollard

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below